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1. Introduction 
Glomerular filtration rate (GFR) is considered as the best way to assess global renal 
function (Gaspari et al., 1997;  Stevens & Levey, 2009). Even if GFR estimations (based on 
creatinine- or cystatin C-based equations) are most often used (see Table 1)(Cockcroft & 
Gault, 1976;  Levey et al., 1999;  Levey et al., 2006;  Levey et al., 2009), measuring “true” 
GFR is still important in clinical practice, especially in particular patients (Delanaye et al., 
2011a;  Delanaye & Cohen, 2008;  Stevens & Levey, 2009). In this chapter, we will review 
the different markers which can be considered as reference methods to measure GFR. 
Before moving to clinical trials, we have to recall the physiological characteristics of an 
ideal GFR marker.  
2. Clearance concept and ideal marker for glomerular filtration rate 
The history of the renal physiology is deeply influenced by the book published by Homer 
W. Smith in 1951 (Figure 1) : « The kidney: structure and function in health and 
disease »(Smith, 1951b). In this best-seller of nephrology, Smith compiled all the 
physiological data (more than 2300 references) which have been published in the scientific 
literature until 1951. Smith, himself, has largely contributed to the physiological knowledge 
of the kidney. A large part of this book is dedicated to the GFR measurement. The concept of 
clearance is well explicated. Actually, the Danish physiologist, Poul Brandt Rheberg was the 
first to use and define the concept of clearance in 1926 even if this author did not use the 
word “clearance”. Rheberg studied on himself the urea and creatinine clearances to prove 
that kidney has a filtrating and not only a secreting action (Rehberg, 1926b;  Rehberg, 1926a). 
The term clearance was used for the first time by Möller in 1929 and was then concerning 
the urea clearance which was proposed as the first evaluation of renal function (Möller et al., 
1929). Smith has largely contributed to make popular and classical this concept of clearance 
to assess GFR (Smith, 1951a). Renal clearance of a substance is defined as the volume of 
plasma cleared from this substance per time unit (mL/min). Clearance is thus a virtual 
volume but will permit to apprehend GFR and renal function. However, the concept of 
clearance is applicable to any internal or external substances. To be considered as a reference 
method, a marker must have strict physiological characteristics  (Smith, 1951b): 
1. Marker production and marker plasma concentration must be constant if GFR does not 
change 
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2. Marker must be free in plasma (not binding to protein) and must be freely and fully 
filtrated through the glomerulus 
3. Marker is neither secreted nor absorbed by renal tubules 
4. Marker must be inert and, of course, not toxic  
5. Marker excretion must be exclusively excreted by kidneys 
6. Marker must be easily measured in both plasma and urine  
 
 
Table 1. Creatinine-based equations. SCr: Serum Creatinine, GFR: glomerular filtration rate, 
MDRD: Modified diet in renal disease, CKD-EPI: Chronic Kidney Disease-Epidemiology 
group. 
 
 
Fig. 1. Homer W. Smith  
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The renal clearance will be easily calculated with the following equation: 
GFR=([U] x V) / [P]  
(where [U] = urinary concentration, [P] = plasma concentration, V = urinary volume)  
The calculated value will be then divided by the time interval where the urine collection has 
been made. Sensu strict, the plasma concentration must be sampled from arterial blood but 
errors induced by venous samples are very limited (Laake, 1954;  Handelsman & Sass, 1956;  
Nosslin, 1965). In the same view, the transit time through the urinary system should also be 
taken into consideration but, once again, error linked to this transit time is negligible 
(Ladegaard-Pedersen, 1972; Nosslin, 1965). The method originally proposed by Smith for 
measuring GFR is not an easy task. Actually, the marker (inulin see below) must be 
intravenously injected and then perfused at a constant rate to reach stable plasma concentrations. 
Thereafter, urine collection must be realized, which is a potential source of errors. For this 
reason, Smith recommended urine collection on 10 and 15 minutes with the use of urinary 
catheter. Smith recommended three successive collections. The patient was hydrated to 
assume a sufficient urinary flow though these collections. The mean of the three collection was 
considered as the GFR measurement (Smith, 1951a). Nowadays, the urine collections are done 
without urinary catheter and on a longer period of time (60 minutes) to decrease the impact of 
urine collection errors on the final result (Levey et al., 1991;  Robson et al., 1949). 
The ideal marker does not exist in the organism (or has still not been discovered if we want 
to be optimistic). Both urea and creatinine clearance have strong limitations, notably because 
creatinine is secreted and urea is absorbed by renal tubules (Dodge et al., 1967;  Morgan et 
al., 1978). Therefore, exogenous markers are used to measure GFR. We will successively 
describe the markers which are still used in clinical practice in 2011: inulin, 51Cr-EDTA, 99Tc-
DTPA, iothalamate and iohexol. For every marker, we will describe strengths and 
limitations both from an analytical and clinical point of view.  
3. Inulin  
Inulin is still considered nowadays as the gold standard to measure GFR. Smith has deeply 
studied this marker and makes it the most popular. Inulin is a polymer of fructose which is 
found in some plants which uses it as energy provider in place of amidon. Its molecular 
weight is 5200 Da (Gaspari et al., 1997). Some plants are especially rich in inulin: chicory, 
garlic, leek and Jerusalem artichoke. Humans are not able to metabolize inulin. Because 
inulin is the first reference method to have been used, its role in the GFR measurement has 
only be asserted on basis of physiological studies (because the first method is not 
comparable to any other !). Once again, we often refer to the studies published by Smith and 
Shannon (New York university)(Smith, 1951a;  Smith, 1951c) and by another pioneer 
Richards (Philadelphia university)(Richards et al., 1934). Inulin was obviously considered as 
a safe product with any effect on GFR (Shannon, 1934). Inulin is freely filtrated through a 
semi-permeable membrane which is a strong argument for the absence of binding to 
protein. This has been shown by Shannon in 1934 (Shannon, 1934) and by Richards in 1937 
(Hendrix et al., 1937). In the same publication, Richards proved that inulin was freely and 
fully filtrated through the glomerulus because he measured the same inulin concentration 
both in the plasma and the glomerulus of a frog and a salamander (Hendrix et al., 1937). The 
absence of both tubular absorption and secretion has been demonstrated by an important 
article published by Shannon in 1934 (Shannon, 1934). In this article, this author showed the 
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absence of inulin excretion in two types of aglomerular fishes (goosefish, Lophius piscatorius 
and toadfish Osteichthyes - Lophiidae). In the same article, Shannon measured GFR by inulin 
clearance in another type of fish with glomerulus, the dogfish (Chondrichthyes – Squalidae). 
These fishes were then treated with phlorizin which was sensed to block all tubular activity. 
Although the creatinine clearance in this fish was increased, the inulin clearance was not 
modified by this treatment (Shannon, 1934). In the same year of 1934, inulin clearance was 
also measured in aglomerular fish and in dogs by Richards (Richards et al., 1934). The 
experimentation (measuring GFR with and without phlorizin) was then repeated in man by 
Smith and Shannon. The results obtained in animals were confirmed in humans. Shannon 
was the first human who was perfused by inulin in 1935 (Shannon & Smith, 1935;  Smith, 
1951c). These authors had thus suggested that inulin was not secreted by renal tubules. This 
assertion will be thereafter confirmed by other authors with the same type of methodology 
(Shannon & Smith, 1935;  Alving et al., 1939;  Laake, 1954). Additional arguments were 
developed in the sixties by animal studies using micropontions in the tubules (Gutman et 
al., 1965). After intravenous injection, inulin is fully excreted by kidneys in urine (Shannon 
& Smith, 1935), even if very low concentrations of inulin are found in bile (Höber, 1930;  
Schanker & Hogben, 1961). 
Inulin is doubtless the marker who has been the most investigated from a physiological 
point of view. In this view, it is logical that inulin is still considered as the gold standard 
for GFR measurement. Nevertheless, there are limitations to its use in daily practice. 
Because its relatively high molecular weight (5200 Da), the molecule is relatively viscous 
and don’t quickly reach its volume of distribution. Therefore, only methods using urinary 
clearance with constant infusion rate seem accurate for this marker. Such methods are 
more cumbersome. Moreover, inulin is not easily available on the market and remains 
relatively costly. From our point of view, the most important limitation of inulin is the 
difficulty linked to its measurement in urine and plasma. Actually, several methods have 
been proposed and these methods are probably not interchangeable. There is no 
standardization in inulin measurement. We have shown that GFR results could vary from 
-10 to +10 mL/min in the same patient only because inulin was measured by a different 
method (unpublished data). Moreover, most of the methods (except the enzymatic ones) 
are prone to interferences with glucose measurement which is a limiting factor when 
measuring GFR in diabetic patients  (Little, 1949). Regarding the methods for measuring 
inulin, we can cite the “acid” methods (Kuehnle et al., 1992;  Shaffer & Somogoyi, 1933;  
Alving et al., 1939;  Corcoran, 1952;  Rolf et al., 1949;  Roe, 1934;  Steinitz, 1938;  Hubbard 
& Loomis, 1942;  Lentjes et al., 1994;  Heyrovsky, 1956;  Rolf et al., 1949), the enzymatic 
methods (Day & Workman, 1984;  Delanghe et al., 1991;  Jung et al., 1990;  Summerfield et 
al., 1993;  Dubourg et al., 2010) and the new methods by high performance liquid 
chromatography (HPLC) (Ruo et al., 1991;  Baccard et al., 1999;  Dall'Amico et al., 1995;  
Pastore et al., 2001). Describing these methods in detail are beyond the scope of this 
chapter and we propose the readers the following reference if they are interested in this 
topic (Delanaye et al., 2011b).  
4. Preliminary statistical considerations  
The use of inulin as GFR marker is justified by physiologic studies. The others markers 
that will be proposed thereafter will be compared to inulin measurements. Therefore, the 
use of other markers will be justified not by physiological studies (even if some 
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physiological studies exist for some markers) but by studies comparing these markers 
with inulin. Unhopefully, most of these studies comparing different GFR tests lack of 
strong statistical methodology. Actually, most of the authors have only shown a good 
correlation between the markers, which is expected but not sufficient. Ratio of new 
markers results on inulin results are also used (the result being considered as good if ratio 
is near to 1). The use of such ratio may be misleading (for example, if one method 
overestimates true GFR in low GFR levels but underestimates GFR in high levels, the ratio 
will be near to 1 although the method is actually not precise enough). To compare the 
performance of a new GFR measurement compared to inulin, we need to know the bias 
(mean difference between the two results) and the precision (standard deviation (SD) 
around the bias) of this new measurement. Bland and Altman analysis is thus required 
(Bland & Altman, 1986). 
Regarding the other GFR markers, we must also stress that GFR can be measured by plasma 
clearance and using a bolus injection (instead of constant infusion rate) which makes the 
GFR measurement much more simple. Method to measure GFR by plasma clearances can be 
very different (number of samples, timing of samples, mathematical model used). We must 
keep in mind that results of plasma and urinary clearances are not strictly comparable 
(plasma clearances overestimate urinary clearances even if the overestimation decreases if 
plasma samples are drawn after 24 hours) and this must be integrated when these GFR 
methods are compared (Agarwal et al., 2009;  Stolz et al., 2010).  
5. 
51
Cr-EDTA (Ethylenediaminetetra-acetic acid) 
5.1 Physiological and analytical data 
51Cr-EDTA is an isotopic marker which has a low molecular weight (292 Da). Most of the 
authors consider that 51Cr-EDTA is not binding to proteins (<0,5% (Brochner-Mortensen, 
1978;  Bailey et al., 1970;  Garnett et al., 1967;  Stacy & Thorburn, 1966;  Forland et al., 1966;  
Kempi & Persson, 1975;  Forland et al., 1966)) even if Rehling described a binding to 
protein of 10% (Rehling et al., 1995;  Rehling et al., 2001). Due to its low molecular weight, 
51Cr-EDTA is freely filtrated through the glomerulus. Physiological studies about renal 
handling of 51Cr-EDTA are few but it seems that 51Cr-EDTA is neither secreted nor 
absorbed by renal tubules (Eide, 1970). This absence of secretion and absorption is also 
confirmed by Forland in dogs (Forland et al., 1966). Regarding the potential extra-renal 
excretion of 51Cr-EDTA, Garnett described a salivary and a fecal excretion under 1% in 
one anephric patient (Garnett et al., 1967). Brochner-Mortensen later confirmed the poor 
fecal excretion (less than 0.1% of the injected dose). Studying the renal excretion and the 
corporal global radioactivity of 8 healthy subjects after 72 hours, Brochner-Mortensen 
estimated that 4.5% of the 51Cr-EDTA will be retained in the body, especially in the liver 
and kidneys (Brochner-Mortensen et al., 1969). The difference between 51Cr-EDTA total 
clearance and 51Cr-EDTA  urinary clearance corresponds to extra-renal clearance of the 
marker. With this methodology, the same authors estimated extra-renal clearance at 4 
mL/min (and this extra-renal clearance remains stable for all GFR ranges)(Brochner-
Mortensen & Rodbro, 1976). Jagenburg had also calculated an extra-renal clearance of 2 
mL/min in two anuric dialysis patients (Jagenburg et al., 1978). Only, Rehling described a 
higher extra-renal clearance at 8.4% (Rehling et al., 1995). 
Measurement of 51Cr-EDTA by nuclear count is very precise and easy because 51Cr-EDTA 
half time is long (27 days)(Chantler et al., 1969). The quantity of 51Cr-EDTA injected is 
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relatively small and therefore the irradiating dose received by the patient is very limited 
(absorbed dose from 0.011 to 0.0077 mSv according to the radioactive dose injected which is 
usually 7 MBq). This absorbed dose corresponds to the natural dose of irradiation received 
in one week and is much lesser than the dose received after thoracic radiography (0.02 mS). 
Nevertheless, we do not recommend this technique to measure GFR in pregnant women 
even if authors seem to use it safely (Brochner-Mortensen, 1978;  Medeiros et al., 2009;  
Durand et al., 2006). The dose of EDTA is 1000x lesser than the dose considered as safe 
(Chantler et al., 1969).  
5.2 Clinical data 
The first studies about 51Cr-EDTA  have been published in the sixties, even if studies (but 
with questionable methodology) had been published before with EDTA marked with 14Cr 
(Spencer et al., 1958;  Foreman & Trujillo, 1954). In 1964, Downes was the first to give 51Cr-
EDTA to cows to study the intestinal transit (Downes & Mcdonald, 1964). In 1966, Stacy and 
Thorburn are the first to inject 51Cr-EDTA to lambs for measuring GFR. They reported a 
good correlation with inulin clearance in the animal model (ratio 51Cr-EDTA/inulin was 
0,95)(Stacy & Thorburn, 1966). The first scientists who will be interested in GFR 
measurement by 51Cr-EDTA in humans are English (Garnett et al., 1967;  Favre & Wing, 
1968;  Garnett et al., 1967;  Heath et al., 1968;  Lavender et al., 1969). It must be underlined 
that nearly all studies published on this marker are coming from Europe because 51Cr-EDTA 
is not available in USA (not approved by the FDA)(Brandstrom et al., 1998). The first author 
who studied 51Cr-EDTA in humans is Garnett who was nuclearist in Southampton. These 
first data were published in The Lancet in 1967 (Garnett et al., 1967). This author injected 
one unique dose of 51Cr-EDTA and described a mono-exponential decrease in 51Cr-EDTA 
concentrations after 30 minutes. This author already evoked the plasma clearance (and the 
bolus injection) to measure GFR with 51Cr-EDTA. Unhopefully, Garnett did not compare his 
results to inulin clearance but only to creatinine clearance. However, Garnett performed and 
compared 56 51Cr-EDTA urinary clearances with inulin urinary clearances. He found a 
correlation of 0.995 and asserted that 51Cr-EDTA result were between ±5% of the inulin 
results which was really excellent. Thereafter, several studies were published on the same 
topic to compare performances of inulin clearance with urinary or plasma clearance of 51Cr-
EDTA. We resumed these studies in Table 2, restricting the data to studies in adults. 
However, once again, the following conclusions will be drawn from studies having used 
the most adequate statistical methods. Globally, the performance of 51Cr-EDTA is good. 
Chantler, in 1969, showed that results of urinary clearance of 51Cr-EDTA was within 5% of 
the results of inulin (Chantler et al., 1969). This excellent concordance between urinary 
clearances of 51Cr-EDTA and inulin will be later confirmed by Froissart. This author 
showed a bias of +3 mL/min (51Cr-EDTA thus slightly overestimating inulin) and a 
precision of ± 4 mL/min (95% of the 51Cr-EDTA results will be + or – 8 mL/min around 
the bias)(Froissart et al., 2005b). The best study comparing 51Cr-EDTA plasma clearance 
with inulin clearance is certainly published by Medeiros in 2009 (Medeiros et al., 2009). 
This author showed that bias between the two GFR was 3±6 mL/min. This is one of the 
rare studies where accuracy 30% results are given (defined as the percentage of patients 
having a 51Cr-EDTA GFR within 30% of inulin GFR). Accuracy 30% for plasmatic 
clearance of 51Cr-EDTA is 93%. The higher performance is obtained when late blood 
samples (at 6 or 8 h) are considered. 
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References Sample Population GFR range 
(mL/min/ 
1.73 m²) 
GFR methods Statistics Results 
(Garnett et 
al., 1967) 
56  NA ± 0 to 180 Urinary clearance 
and constant 
infused rate 
Regression 
Correlation 
 
=1.075x-3.06 
0.995 
 
(Heath et al., 
1968) 
39 Healthy 
CKD 
Calcium 
troubles 
10 to 150 Urinary clearance 
and constant 
infused rate 
Correlation 0.995 
51Cr-EDTA 
underestimat
es by de 14-
16% 
(Favre & 
Wing, 1968) 
20 CKD 6 to 187 Urinary clearance 
and constant 
infused rate 
Ratio  
Correlation 
BAr 
1.02 
0.992 
1.5±8.7 
(Lavender et 
al., 1969) 
100 
clearances 
in 28 
subjects 
CKD ± 0 to 150 Urinary clearance 
and constant 
infused rate 
Ratio 
Regression 
Correlation 
0.96 ± 0.0027 
=0.96x+0.26 
0.994 
(Brochner-
Mortensen et 
al., 1969) 
17 2 healthy ± 10 to 130 Inulin: urinary 
clearance and 
constant infused 
rate 
51Cr-EDTA : 
plasmatic clearance: 
on 5 hours, samples 
every 15 min 
Correlation 
Regression 
0.974 
=1.017x+1.6 
(Chantler et 
al., 1969) 
21 CKD ± 10 to 160 Urinary  
clearance and 
constant infused 
rate 
Correlation 
Regression 
Ratio 
0.977 
=1.004x-0.032 
1.004±0.013 
(Stamp et al., 
1970) 
65 
clearances 
in 56 
subjects 
15 healthy 
41 calcium 
troubles 
± 20 to 140 Urinary clearance 
and constant 
infused rate 
 
Correlation 
Regression 
Ratio 
0.91 
=0.98x+6.5 
0.96±0.02 
(Ditzel et al., 
1972) 
20  NA 6 to 166 Inulin: urinary 
clearance and 
constant infused 
rate 
51Cr-EDTA : 
plasmatic clearance: 
samples at 5,10, 15, 
20, 30, 60, 90, 120, 
150, 180, 210, 240 
min 
Correlation 
Regression 
BAr 
 
0.97 
=0.85x+11.42 
1.5±11.7 
(Lingardh, 
1972) 
25 Healthy and 
CKD 
±8 to 120 Inulin: urinary 
clearance  
and constant 
infused rate 
51Cr-EDTA : 
plasmatic clearance: 
samples timing not 
available 
Correlation 
Regression 
Mean 
difference 
 
0.984 
=1.099x+4.96 
 
6.2 mL/min 
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(Brochner-
Mortensen, 
1973) 
89 
clearances 
in 9 subjects 
Healthy, before 
and after 
hyperglycemia 
130 to 150 Urinary clearance 
and constant 
infused rate 
Ratio 0.9±0.01 
(Hagstam et 
al., 1974) 
29 CKD ± 30 to 160 Urinary clearance 
and constant 
infused rate 
Correlation 
Regression 
Ratio 
0.97 
=0.855x+7.555 
0.96±0.07 
(Hagstam et 
al., 1974) 
31 CKD ± 30 to 160 Inulin: urinary 
clearance and 
constant infused 
rate 
51Cr-EDTA : 
plasmatic clearance: 
samples at 
180, 200, 220 et 240 
min + BM 
correction 
Correlation 
Regression 
Ratio 
0.97 
=0.961x+2.908 
1±0.11 
(Winterborn 
et al., 1977) 
16 Children and 4 
healthy adults 
± 5 to 120 Inulin: urinary 
clearance and 
constant infused 
rate 
51Cr-EDTA : urinary 
clearance: 
Correlation 
Regression 
 
0.99 
=0.96x+3.5 
 
 
(Jagenburg et 
al., 1978) 
17 Severe CKD 2.6 to 11 Urinary clearance  Correlation 
Regression 
0.97 
=1.05x-0.3 
 (Rehling et 
al., 1986) 
19 Nephrectomy 11 to 76 Inulin: urinary 
clearance and 
constant infused 
rate 
51Cr-EDTA : 
plasmatic clearance: 
5 samples between 
3 and 5 h+BM 
correction  
Correlation 
Regression 
SD around 
the mean 
difference 
0.96 
=0.86x+2.4 
4.3 mL/min 
 
 
 
(Froissart et 
al., 2005b) 
111 NA NA Urinary clearance 
and constant 
infused rate 
BA 2.7±3.5 
(Froissart et 
al., 2005a) 
22 NA NA Urinary clearance 
and constant 
infused rate 
BA 4±4.9 
(Medeiros et 
al., 2009) 
   44 Renal grafted ±15 to 80 Inulin: urinary 
clearance and 
constant infused 
rate 
51Cr-EDTA : 
plasmatic clearance: 
samples at 2, 4, 6, 8 
h 
+ BM correction  
t-test 
Correlation 
BA 
Exactitude 
30% 
NS 
0.94 
2.5±6.1 
90.9% 
 
Table 2. Studies comparing 51Cr-EDTA with inulin. NA: not available, CKD: chronic kidney 
disease subjects, BA: Bland and Altman analysis, BAr: Bland and Altman analysis re-
calculated by us, BM: Brochner-Mortensen. 
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5.3 Strengths and limitations 
51Cr-EDTA clearance was the first published alternative to inulin. Among the strengths of 
this marker, we have to underline the good performance of GFR measurement comparing to 
inulin (or to other markers). Physiological profile can also be considered as satisfying. This 
marker is yet easy to measure (especially according to its long half-life) and the precision of 
the measurement appears excellent. The costs, compared to other GFR markers, are 
acceptable. One important limitation is linked to the fact that 51Cr-EDTA GFR must be done 
in a Nuclear Medicine department. The most important limitation of this marker is the non-
use in USA, where 51Cr-EDTA is not recognized by the FDA. 
6. 
99
Tc-DTPA (Diethylenetriaminepenta-acetic acid) 
6.1 Physiological and analytical data 
Like 51Cr-EDTA, 99Tc-DTPA is an isotopic marker with a low molecular weight (393 
Da)(Durand et al., 2006). DTPA may be labeled with another isotopic marker (113mIndium 
(Johansson & Falch, 1978;  Reba et al., 1968;  Piepsz et al., 1974), 169Ytterbium (Perrone et 
al., 1990;  Russell et al., 1985)) but technetium 99 is the most used up to now. The 99Tc-
DTPA  is also used in Nuclear Imagery (isotopic nephrogram) for instance to measure 
separately the function or the right and left kidney (Biggi et al., 1995;  Hilson et al., 1976;  
Kainer et al., 1979). However, we will only discuss GFR measurement based on plasma 
and/or urinary methods with 99Tc-DTPA. GFR can also be estimated with external 
counting using gamma camera (namely the “Gates” method) (Gates, 1984; Russell, 1987)  
but this method is not precise enough to be considered as a reference method for 
measuring GFR. For some authors, the GFR estimation given by the Gates method is even 
less performing than the creatinine clearance (Owen et al., 1982;  Goates et al., 1990;  van 
de Wiele C. et al., 1999;  Ma et al., 2007;  Mulligan et al., 1990;  Galli et al., 1994;  Ginjaume 
et al., 1985;  Rodby et al., 1992;  Tepe et al., 1987;  Aydin et al., 2008;  De Santo et al., 1999;  
Fawdry et al., 1985;  Durand et al., 2006).  
Doses of injected 99Tc-DTPA are totally safe (10 MBq)(Kempi & Persson, 1975;  Durand et al., 
2006). If the GFR measurement is coupled with nephrogram, the radioactive dose is 
however 40 to 200x higher than a simple GFR measurement with 51Cr-EDTA (Kempi & 
Persson, 1975;  Griffiths et al., 1988). The half-life of 99Tc-DTPA is short (6.05 h) which 
imposes that the GFR measurement is realized quickly after the samplings, which is a 
practical inconvenient compared to 51Cr-EDTA (Owen et al., 1982). The 99Tc-DTPA 
measurement is as precise as other isotopic methods. The most relevant critic regarding 99Tc-
DTPA is its potential binding to protein. This aspect has been debated in the literature. Some 
authors described a binding to plasma proteins from 2 to 13%, which implies an 
underestimation of GFR, especially when GFR is measured by plasmatic clearance (Kempi & 
Persson, 1975;  Agha & Persson, 1977;  Klopper et al., 1972;  Biggi et al., 1995;  Houlihan et 
al., 1999;  Rehling et al., 2001). These high percentages could however been explained by the 
lack of purity of the first available preparations of 99Tc-DTPA (Rootwelt et al., 1980;  Rehling 
et al., 2001;  Fleming et al., 2004;  Carlsen et al., 1980;  Russell et al., 1983;  Kempi & Persson, 
1975). This hypothesis has been well illustrated in 1980 by Carlsen who studied and 
compared 51Cr-EDTA clearances with 4 different commercial preparations of 99Tc-DTPA. 
This author showed different results according to the preparation used (Carlsen et al., 1980). 
The binding to protein may also be studied by different methodologies (ultrafiltration, 
electrophoresis, precipitation, in vitro or in vivo, in humans or in animals  etc)(Rehling et al., 
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2001;  Russell et al., 1983;  Jeghers et al., 1990). For example, Rehling found a binding to 
protein of 10-13% but this author was also the only one who found a significant and 
comparable binding to protein for  51Cr-EDTA and iothalamate (Rehling et al., 2001). The 
subject is finally still debated (Jeghers et al., 1990). Another potential critic about 99Tc-DTPA 
is the very poor available data on its physiological handling. A study in a dog model argued 
for the absence of tubular secretion and reabsorption  (Klopper et al., 1972).  
6.2 Clinical data 
There are hopefully much more clinical studies comparing 99Tc-DTPA with other markers. 
After the preliminary study published by Hauser (Hauser et al., 1970),  the performances of 
99Tc-DTPA clearance was studied from the seventies. Klopper may be considered as one of 
the pioneers with this markers (Klopper et al., 1972). The first studies were however 
comparing 99Tc-DTPA with iothalamate and the samples were limited (Table 6)(Klopper et 
al., 1972; Rootwelt et al., 1980). The first study comparing 99Tc-DTPA with inulin was 
published in 1984 (Rehling et al., 1984). In table 3, we resumed the results of studies 
comparing 99Tc-DTPA with the gold standard method in adults. Two studies have 
compared with good statistical methods the urinary clearance of 99Tc-DTPA and inulin. In 
the study published by Lewis in 1989, the bias was excellent bias (near to 0) but the precision 
was not satisfying (± 18 mL/min)(Lewis et al., 1989). One year later, Perrone showed 
excellent concordance between urinary clearances of 99Tc-DTPA and inulin in 13 chronic 
kidney disease (CKD) patients. However, the results were less impressive in the 4 healthy 
subject where 99Tc-DTPA clearances overestimate (+12 mL/min) inulin clearances. 
Definitive conclusion about the performance of 99Tc-DTPA plasmatic clearance is difficult to 
draw and we clearly need additional studies on this topic.   
6.3 Strengths and limitations 
99Tc-DTPA presents the advantages and inconvenient of other isotopic methods (see 51Cr-
EDTA paragraph). The dosage of the marker is relatively cheap and precise. His short half-
time makes it a few less practicable than 51Cr-EDTA. Among the most important advantages 
of 99Tc-DTPA, we underline the fact that it is the only marker that can be coupled with 
nephrogram to give separated function between the two kidneys (Durand et al., 2006). 
Physiological data to confirm its role as a reference marker are however clearly lacking. We 
also think that global performance of 99Tc-DTPA compared to inulin is probably a few less 
than the 51Cr-EDTA, especially with plasma clearances (at least in part because 99Tc-DTPA is 
binding to proteins). 
7. Iothalamate  
7.1 Physiological and analytical data 
Iothalamate is an ionic contrast product which was particularly used for urography. 
Iothalamate is derived from the tri-iodobenzoic acid. Its molecular weight is 637 Da 
(Schwartz et al., 2006) and it is freely distributed into the extracellular volume (Visser et al., 
2008). From a historical point of view, iothalamate was not the first contrast agent used to 
measure GFR. Other derivates from tri-iodobenzoic acid had been tested at the end of the 
fifties. Diatrizoate (Hypaque) was proposed by some authors as a potential GFR marker 
because it is fully excreted by the kidneys (Meschan et al., 1963;  Burbank et al., 1963;  Stokes 
et al., 1962;  Mcchesney & Hoppe, 1957). However, other authors suggested that  
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References Sample Population GFR range 
(mL/min/ 
1.73 m²) 
GFR methods Statistics Results 
(Rehling et 
al., 1984) 
20 Nephrectomy 11 to 76 Inulin: 
urinary and 
plasma 
clearance with 
bolus 
99Tc-DTPA: 
Urinary and 
plasma 
clearance: 
samples at 5, 
10, 20, 40, 60, 
90, 120, 150, 
180, 210, 240, 
270, 300 min  
 
Wilcoxon 
 
 
 
Ratio urinary 
 
plasma 99Tc-
DTPA and 
urinary 
clearance of 
inulin  
Correlation 
Regression 
urine : p<0.05 
 plasma : 
p<0.05 
 
0.97 
 
0.97 
=0.93x+6.8 
(Shemesh et 
al., 1985) 
45 NP ±10 to 140 
 
Inulin: 
urinary 
clearance and 
constant 
infused rate 
99Tc-DTPA 
urinary 
clearance 
Correlation 
Ratio 
0,969 
1,02±0,14 
 
 
 
 
 
(Notghi et al., 
1986) 
37 Healthy and 
CKD 
7 to 182 
 
Inulin: 
urinary 
clearance and 
constant 
infused rate 
99Tc-DTPA 
plasma 
clearance: 
samples at: 60 
and 150 min 
Correlation 
Regression 
0.77 
=0.94x+33.7 
(Petri et al., 
1988) 
NA Lupus 23 to 123 Inulin: 
urinary 
clearance and 
constant 
infused rate 
99Tc-DTPA: 
urinary 
clearance with 
bolus  
Correlation 
Regression 
r² 
0.96 
=x+4.4 
0.93 
(Lewis et al., 
1989) 
29 10 heart 
grafted 
11 renal grafted 
10 donors 
10 to 117 Inulin: 
urinary and 
plasma 
clearance with 
bolus 
99Tc-DTPA: 
urinary 
clearance with 
bolus  
Correlation 
Regression 
BAr 
 
0.85 
=0.84x+8.4 
0±18 
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 (Perrone et 
al., 1990) 
13 
 
 
 
 
 
 
 
 
 
4 
CKD 
 
 
 
 
 
 
 
 
 
Healthy 
 
2 successive 
days 
±5 to 130 Inulin: 
urinary 
clearance and 
constant 
infused rate 
99Tc-DTPA 
urinary 
clearance with 
bolus   
Wilcoxon or 
t-test 
Correlation 
 
BA 
 
 
 
 
P<0.001 
 
from 0.93 to 
0.98 
Day 1 
+0.5±3 
Day 2 
-2±3 
 
 
Inulin (day 1 
and 2): 
108±14  
96±8  
99Tc-DTPA (day 
1 and 2) 
122±24  
108±17  
(Wharton, III 
et al., 1992) 
18 
 
Intensive care 
and CKD 
2 to 69 Inulin: 
urinary 
clearance and 
constant 
infused rate 
99Tc-DTPA 
urinary 
clearance with 
bolus   
Correlation 
Regression 
 
 
 
 
0.85 
=1.12x 
 
 
 
 
(Gunasekera 
et al., 1996) 
15 NA ±25 to 160 Bolus and 
plasma 
clearance for 
inulin and 
99Tc-DTPA: 6 
samples 
within the 
first hours, 3 
or 4 samples 
between 2 and 
4 h 
Correlation 
Regression 
=0.98x-0.4 
0.98 
Table 3. Studies comparing 99Tc-DTPA with inulin. NA: not available, CKD: chronic kidney 
disease subjects, BA: Bland and Altman analysis, BAr: Bland and Altman analysis re-
calculated by us, BM: Brochner-Mortensen.  
diatrizoate (as other derivates from tri-iodobenzoic acid) was secreted by renal tubules 
(Woodruff & Malvin, 1960;  Harrow, 1956;  Winter & Taplin, 1958). In 1961, Denneberg is the 
first to compare diatrizoate labeled with l131 and inulin in human (Denneberg et al., 1961). 
This author described a higher renal excretion and then confirmed that diatrizoate is 
secreted by renal tubules (Denneberg et al., 1961). Diatrizoate was still studied by some 
authors in the next years but the interest has definitively moved from diatrizoate to 
iothalamate (Burbank et al., 1963;  Morris et al., 1965;  Dalmeida & Suki, 1988;  Owman & 
Olin, 1978;  Donaldson, 1968).  
As we will describe in the next paragraph, interest in iothalamate as a GFR marker has 
grown from the mid-sixties with the studies proposed by Sigman (Sigman et al., 1965a;  
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Sigman et al., 1965b). For this author, the binding of iothalamate to protein is less than 3% 
(Sigman et al., 1965b). Such result was confirmed by most of the authors thereafter 
(Anderson et al., 1968;  Gagnon et al., 1971;  Blaufox & Cohen, 1970;  Prueksaritanont et 
al., 1986;  Back et al., 1988b), except for Maher and Rehling (see 99Tc-DTPA 
chapter)(Rehling et al., 2001;  Maher & Tauxe, 1969). Rapidly, Sigman has proposed to 
move from labeling with I131 to labeling with I125.  I125 is actually more stable (Elwood & 
Sigman, 1967;  Maher et al., 1971). I125-Iothalamate is thus an isotopic method which is 
precise and safe. The half-life of 125I is 60 days (Perrone et al., 1990). Physiological data on 
iothalamate have been published after the first clinical studies by Sigman. Iothalamate 
was then studied in aglomerular fishes and only 3% of injected iothalamate was found in 
urine. The absence of tubular secretion and reabsorption was confirmed in a dog model 
(Griep & Nelp, 1969). However, these reassuring results were not confirmed by Odlind in 
1985. This author actually observed in rats a tubular secretion of iothalamate (comparing 
with 51Cr-EDTA and using inhibitors of tubular secretion). In the same view, Odlind 
described, in 6 healthy subjects, that iothalamate clearance overestimates inulin clearance 
and that this overestimation is reversible after inhibition of tubular secretion by 
probenecid (Odlind et al., 1985). In anephric patients, Cangiano described an extra-renal 
excretion of iothalamate that reached 4 to 8 mL/min. This extra-renal excretion fall to 0 
after thyroid saturation by iodine (Cangiano et al., 1971). A potential limited extra-renal 
clearance of iothalamate was thus suggested in the thyroid. Evans described a clearance of 
iothalamate of 3.1±1.8 mL/min in 7 dialysis patients (among these, 5 were anuric). In 
animal models, a limited biliary excretion is suggested by some authors (Owman & Olin, 
1978;  Prueksaritanont et al., 1986). Comparing the total (i.e. plasma) and the renal 
clearance of iothalamate in healthy subjects, Back calculated the extra-renal clearance at 6 
mL/min (Back et al., 1988b). In the same experience,  Dowling calculated extra-renal 
clearance at 10 ml/ml, which was constant for all the GFR levels (sample of 26 
patients)(Dowling et al., 1999). In this last study, the plasma clearance was measured until 
180 min, which may be considered as too short (Dowling et al., 1999). Visser has also 
calculated the urinary excretion of iothalamate on 24 h and estimated the extra-renal 
excretion at 14±12% (Visser et al., 2008). Such values of extra-renal clearances are thus not 
so negligible, especially when it is considered in patients with severe CKD. Actually, the 
relative importance of this extra-renal clearance will be higher when the GFR is yet low 
(Visser et al., 2008). 
Iothalamate is a safe product but, of course, it will be not used in subjects presenting a 
known “true” allergy to contrast products (Heron et al., 1984). Regarding the isotopic 
method, the radioactive dose got by the patient is also very low (lower than the dose got for 
thorax radiography)(Hall & Rolin, 1995;  Bajaj et al., 1996). 
Because its relatively low molecular weight, iothalamate is a good marker (just like 51Cr-
EDTA) to be used in simplified protocols. Cohen was the first to use the bolus method 
instead of the constant rate infusing method in 1969 (Cohen et al., 1969). Several authors 
have showed that iothalamate could be used in plasma clearance (LaFrance et al., 1988;  
Welling et al., 1976;  Back et al., 1988b;  Gaspari et al., 1992) even if results are not fully 
comparable to urinary clearances (Agarwal et al., 2009). It must also be underlined that 
iothalamate is the only one marker which is frequently used with subcutaneous injection 
(Israelit et al., 1973). It had actually been shown that plasma iothalamate concentrations 
remain constant 60 to 90 min after a subcutaneous injection (so, equivalent to the constant 
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infusion rate method but much easier) (Israelit et al., 1973;  Adefuin et al., 1976;  Tessitore et 
al., 1979;  Sharma et al., 1997). 
Iothalamate can yet be measured by “cold” non-isotopic methods. The first “cold” dosage of 
iothalamate was proposed in 1975 by Guesry (Guesry et al., 1975). This author used 
fluorescent excitation analysis or X ray fluorescence (XRF), which will be also used for 
iohexol measurement (see below). In this technique, iodine atoms are ionized by 
americanum. When the iodine atom comes back to neutral status, it will emit X ray that will 
be then quantified (Guesry et al., 1975). Guesry found an excellent correlation between 
isotopic and XRF iothalamate measurement. Iothalamate concentration can also be 
determined by electrophoresis but, to the best of our knowledge, this technique is only used 
in the Mayo Clinic (Wilson et al., 1997). The most used methods to measure iothalamate are 
HPLC methods (Boschi & Marchesini, 1981). The HPLC method seems specific, sensible and 
reproducible (CV intra-day lower than 2% and CV inter-day lower than 6%) (Boschi & 
Marchesini, 1981;  Prueksaritanont et al., 1984;  Weber et al., 1985;  Reidenberg et al., 1988;  
Back et al., 1988b;  Gaspari et al., 1991;  Dowling et al., 1998;  Agarwal, 1998;  Kos et al., 2000;  
Agarwal et al., 2003;  Farthing et al., 2005;  Bi et al., 2007). A new technique based on mass 
spectrometry has recently been proposed to measure iothalamate (Seegmiller et al., 2010). 
These authors have compared 51 GFR results given by this new technique and by 
electrophoresis. The results are excellent in term of correlation and bias (0.8%). The SD 
around the bias, namely the precision, is however less negligible at 13.7%. That means that 
95% of the results measures in the same patient may vary from ± 28% according the way 
iothalamate has been measured. Iothalamate measurement remain very stable (for two 
months at room temperature and at –4 and -20°C and for 1 year at -80°C) (Weber et al., 1985;  
Seegmiller et al., 2010).         
7.2 Clinical data 
Iothalamate (Conray°) was used as GFR marker for the first time by Sigman from the New 
York University in 1965 (Sigman et al., 1965a;  Sigman et al., 1965b). In these articles, Sigman 
used iothalamate labeled with 131I and compared its clearance with inulin clearance in 10 
patients in the first publication (Sigman et al., 1965a) and in 16 in the second one (Sigman et 
al., 1965b). On this limited sample, Sigman described a ratio iothalamate/inulin near to 1, 
even though the ranges of this ratio are from 0.74 à 1 in the first study (Sigman et al., 1965a) 
and from 0.937 à 1.138 in the second one (Sigman et al., 1965b). These first interesting results 
were then confirmed by the same authors with 125I-iothalamate (Elwood & Sigman, 1967). 
Other authors published thereafter their own data comparing performance of inulin and 
iothalamate clearances. We resumed the results obtained in adults in Table 4. It is probably 
right to write that iothalamate has been the most studied GFR marker and the marker for 
which several comparisons to inulin exist. Other authors have confirmed the good 
performance of iothalamate urinary clearances, especially in CKD patients (Maher et al., 
1971; Perrone et al., 1990;  Skov, 1970). In healthy subjects, the results are however more 
questionable and iothalamate seems to overestimate inulin (+20 mL/min)(Perrone et al., 
1990) although precision is not optimal ±11 mL/min, as illustrated in the study by Botev 
(Botev et al., 2011). Data regarding the performance of the iothalamate plasma clearance are 
less numerous but is seems that bias is acceptable. However, precision is not optimal, 
especially in higher GFR levels. Additional studies could be of interest for the plasmatic 
method (Agarwal, 2003;  Mirouze et al., 1972). 
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References Sample Population GFR range 
(mL/min/1.73 
m²) 
GFR 
methods 
Statistics Results 
(Sigman et 
al., 1965a) 
10 NA 70 to 108 Inulin: 
urinary 
clearance and 
constant 
infused rate 
131iothalamate
: urinary 
clearance and 
constant 
infused rate 
Ratio 
It/inulin 
BAr 
1.06 
(0.74 to 1.23) 
6±13 
(Sigman et 
al., 1965b) 
24 
clearances 
in 16 
subjects 
NA 2 to 167 Inulin: 
urinary 
clearance and 
constant 
infused rate 
131iothalamate
: urinary 
clearance and 
constant 
infused rate 
t-test 
Ratio 
It/inulin 
BAr 
NS 
1.005 (from 0.937 
to 1.138) 
0.7±4 
(Elwood & 
Sigman, 
1967) 
26 
clearances 
in 21 
subjects 
NA 27 to 136 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate 
Ratio 
It/inulin 
BAr 
1 (from 0.93 to 
1.09) 
1±3 
(Malamos et 
al., 1967) 
19 Healthy and CKD NA Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate 
Ratio 
It/inulin  
Correlation 
(urinary) 
Regression 
1.01±0.19 
 
0.979 
 
It=1.09inulin-0.65 
(Anderson et 
al., 1968) 
18 11 CKD and 8 
healthy 
3 to 139 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate 
Regression 
BAr 
=0.9x+6.7 
-0.7±13 
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(Maher & 
Tauxe, 1969) 
15 hypertensive ±55 to 120 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate 
Ratio 
It/inulin 
Regression 
0.92  
(0.81 to 1.04) 
Inulin=1.08It 
(Skov, 1970) 43 
 
65 
clearances 
in 22 
subjects 
 
38 
clearances 
in 13 
subjects 
 
 
24 
clearances 
in 8 
subjects 
CKD 
 
GFR<5 ml/  
 
 
GFR between 5 et 
15 mL/min  
 
GFR between 15 et 
25 mL/min  
 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: bolus and 
urinary 
clearance  
 
Ratio 
It/inulin 
Correlation 
Regression 
BAr 
Group 1 
0.98±0.06 
 
0.999 
=0.972+0.01 
0±0 
Group 2 
1 
0±1 
 
Group 3 
0.92±0.071 
0.968 
=1.083+3.46 
-2±1 
(Gagnon et 
al., 1971) 
78 
clearances 
in 24 
subjects 
NA ±10 to 180 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate  
Ratio 
It/inulin 
1.01 
 
(Cangiano et 
al., 1971) 
49 
clearances 
in 18 
subjects 
NA ±30 to 150 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate 
Ratio 
It/inulin 
Correlation 
Regression 
1.07 
 
0.94 
=1.06+1.17 
(Maher et al., 
1971) 
 198  NA ±5 to 150 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate  
Bias 
 
Regression 
 
-2.09 
 
Inulin=1.022It+0.5
37 
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(Mirouze et 
al., 1972) 
36 
clearances 
in 23 
subjects 
hypertensive ±5 to 120 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate  
Ratio 
It/inulin 
Correlation 
Regression 
1.44±0.13 
 
0.96 
=1.18+8.43 
(Mirouze et 
al., 1972) 
15  hypertensive ±80 to 140 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
:  
plasma 
clearance: 
samples at 5, 
10, 15, 20, 40, 
60, 80, 100 et 
120 min + 
correction 
Ratio 
It/inulin 
Correlation 
Regression 
1.23±0.16 
 
0.77 
=1.06+1.18 
(Israelit et al., 
1973) 
22 20 CKD 
2 healthy 
6 to 125 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: bolus SC and 
urinary 
clearance  
Ratio 
It/inulin 
Correlation 
Regression 
1.05±0.04 
 
0.97 
=1.054-3.069 
(Rosenbaum 
et al., 1979) 
7 healthy 
9 renal 
grafted 
8 donors 
after 
donation 
 96 to 147 
35 to 87 
42 to 98 
Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: bolus and 
urinary 
clearance  
Ratio 
It/inulin 
 
BAr 
1.02±0.04 
1.43±0.08 
1.23±0.04 
-1±13 
-7±14 
-4±13 
 
 
(Ott, 1975) 84 CKD and donors ±10 to 150 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: urinary 
clearance and 
constant 
infused rate  
Correlation 
Regression 
0.932 
=1.04+2.11 
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(Ott, 1975) 100 CKD and donors ±5 to 150 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: bolus SC and 
urinary 
clearance 
Correlation 
Regression 
0.982 
=1.02-0.61 
(Tessitore et 
al., 1979) 
30 15 creatinine<1 
mg/dL 
15 creatinine<20 
mg/dL 
NA Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: bolus SC and 
urinary 
clearance  
Ratio 
It/inulin 
Correlation 
 
1.07±0.05 
 
0.96 
(Notghi et al., 
1986) 
76 
clearances 
in 40 
subjects 
Healthy and CKD ±10 to 180 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: bolus SC and 
urinary 
clearance  
Correlation 
Regression 
0.86 
=0.8x+19.5 
(Petri et al., 
1988) 
NA  Lupus 23 to 123 Inulin: 
urinary 
clearance and 
constant 
infused rate 
Iothalamate 
(XRF): bolus 
and urinary 
clearance  
Correlation 
Regression 
r² 
0.99 
=0.9x-2.1 
0.99 
(Perrone et 
al., 1990) 
13 
 
 
 
 
4 
 
CKD 
 
 
 
 
Healthy 
Two successive 
days 
±5 to 130 Inulin: 
urinary 
clearance and 
constant 
infused rate 
125iothalamate
: bolus SC and 
urinary 
clearance  
Wilcoxon or 
t-test 
Correlation 
 
 
Means 
 
 
 
P<0.001 
 
from 0.93 to 0.98 
 
 
Inulin : 
108±14 day 1 
96±8 day 2 
125iothalamate 
127±12 day 1 
120±7 day 2 
(al Uzri et al., 
1992) 
5 healthy 120 to 165 Inulin: 
urinary 
clearance and 
constant 
infused rate 
Iothalamate 
(HPLC): 
bolus and 
urinary 
clearance  
ratio 1.00±0.06 
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(Isaka et al., 
1992) 
23 CKD 10 to 130 Inulin: 
urinary 
clearance and 
constant 
infused rate 
Iothalamate 
(HPLC): 
bolus and 
urinary 
clearance  
Correlation 
Slope with 0 
intercept 
0.98 
1.05±0.01 
(Agarwal, 
2003) 
12 
clearances 
in 3 
subjects 
CKD ± 20 to 110 Inulin: 
urinary 
clearance and 
constant 
infused rate 
Iothalamate 
(HPLC): 
plasma 
clearance on 
long time 
with insulin 
pomp 
Bias (Inulin-
It) 
CV 
0.8  
19.9% 
(Botev et al., 
2011) 
Data from 5 
studies 
(Anderson et 
al., 1968;  
Elwood & 
Sigman, 
1967;  
Perrone et al., 
1990;  
Rosenbaum 
et al., 1979;  
Skov, 1970) 
94 See above ± 5 to 140 See above Correlation 
Regression 
BA  
(It-Inulin) 
0.97 
=1.04+2.334 
+4.6±11 
Table 4. Studies comparing iothalamate with inulin. NA: not available, CKD: chronic kidney 
disease subjects, BA: Bland and Altman analysis, BAr: Bland and Altman analysis re-
calculated by us, BM: Brochner-Mortensen, HPLC: high pressure liquid chromatography,  
It: iothalamate, SC: subcutaneous, XRF: X ray fluorescence. 
7.3 Strengths and limitations 
Iothalamate can be measured either by HPLC or XRF methods or by isotopic methods. This 
is the only one marker where this choice is possible. However, there is no evidence that all 
the techniques of measurement are fully equivalent. Iothalamate is certainly the marker that 
has been the most deeply studied from a physiological point of view (with inulin). 
Unhopefully, there are strong reasons to believe that iothalamate is secreted by renal 
tubules. Moreover, extra-renal clearance of iothalamate is not so negligible. These 
limitations are confirmed by most of the clinical studies showing that iothalamate slightly 
overestimates inulin clearance, especially in the high levels of GFR. A clinical limitation 
concerns the patients who are allergic to contrast product. This marker remains however 
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important because it is the most used marker in USA. For example, iothalamate has been 
used in trials having built the new creatinine-based equations (Levey et al., 1999).  
8. Iohexol 
8.1 Physiological and analytical data 
Iohexol is a non-ionic contrast product, mainly used for myelography. Its molecular weight 
is 821 Da (Olsson et al., 1983;  Schwartz et al., 2006). Iohexol is chronologically the last 
marker proposed for measuring GFR. Actually, the first human was receiving iohexol in 
1980 (Aakhus et al., 1980). In this study, it was shown that the substance was safe and fully 
excreted by the kidneys (this assertion will be criticized thereafter, see below). However, 
these authors also describe (but data are not available) a higher urinary clearance of iohexol 
than 51Cr-EDTA (Aakhus et al., 1980). The details of these comparison studies were 
published three years after (see clinical data)(Olsson et al., 1983). In the same study, the 
authors confirm that iohexol is distributed through the extracellular volume, which will be 
confirmed by other authors (including in CKD patients and in obese subjects) (Friedman et 
al., 2010;  Nossen et al., 1995;  Edelson et al., 1984;  Back et al., 1988b;  Olsson et al., 1983). 
Iohexol has not effect per se on GFR (Olofsson et al., 1996). Binding to protein seems very 
limited for iohexol. The first study described a binding to protein of only 1.5% (Mutzel et al., 
1980). This will be thereafter confirmed (Back et al., 1988b;  Krutzen et al., 1984). Physical 
properties of iohexol make it a good candidate to be used in simplified protocols like plasma 
clearance (Thomsen & Hvid-Jacobsen, 1991;  Gaspari et al., 1995;  Edelson et al., 1984). 
Contrary to the prior studies (Aakhus et al., 1980), several authors have shown that extra-
renal clearance of iohexol is limited but not null (Arvidsson & Hedman, 1990;  Krutzen et al., 
1984). Back calculated at 6.2 mL/min the difference between total and urinary clearance of 
iohexol in healthy subjects (Back et al., 1988b). Frennby observed an extra-renal clearance 
lower than 2 mL/min in 6 anuric dialysis patients (Frennby et al., 1994;  Frennby et al., 
1995). These last very low results were also found by Nossen in 16 patients with severe 
CKD. Their mean measured GFR was 14 mL/min and the extra-renal clearance was 
estimated at 10% (Nossen et al., 1995). In 16 healthy subjects, Edelson estimated the extra-
renal clearance of iohexol at 5% (Edelson et al., 1984). Contrary to iothalamate, there are very 
few physiological studies on the renal tubular handling of iohexol. 
As for iothalamate, iohexol can be measured by several different techniques. Among these, 
HPLC and XRF are the most used ones. HPLC was historically the first method used 
(Aakhus et al., 1980) and described (Krutzen et al., 1984). As we have shown, iohexol 
measurements by HPLC are sensitive, specific and reproducible (Back et al., 1988c;  Farthing 
et al., 2005;  Cavalier et al., 2008). The high performance of such dosage notably enables the 
use of iohexol low doses and the measurement on finger-prick samples (Krutzen et al., 1990;  
Niculescu-Duvaz et al., 2006;  Mafham et al., 2007;  Cavalier et al., 2008;  Aurell, 1994). 
Iohexol measurement is also pretty stable at room temperature and at -20°C(Krutzen et al., 
1984;  O'Reilly et al., 1988). Measurement of iohexol by XRF method is less validated and 
probably less performing, especially in low plasma concentrations (O'Reilly et al., 1986;  
Back & Nilsson-Ehle, 1993;  Effersoe et al., 1990;  Brandstrom et al., 1998;  Aurell, 1994). We 
will not discuss into details the other methods for measuring iohexol: capillary 
electrophoresis (Shihabi & Constantinescu, 1992) and mass spectrometry (Lee et al., 2006;  
Annesley & Clayton, 2009;  Denis et al., 2008;  Stolz et al., 2010). The safety of iohexol is now 
confirmed (Heron et al., 1984;  Aurell, 1994), notably by the largest series of iohexol 
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measurements in Sweden (1500 GFR measurements/y)(Nilsson-Ehle & Grubb, 1994;  
Nilsson-Ehle, 2002). This safety profile is, at least in part, explained by the low dose of 
iohexol injected, and by the exclusion of patients with contrast products allergy. 
8.2 Clinical data  
The results of the first clinical study on iohexol as a reference GFR marker will be published 
in 1983 (Olsson et al., 1983). Actually, GFR was measured in 10 healthy subjects with urinary 
clearances of iohexol and 51Cr-EDTA. In this study, the iohexol clearance was significantly 
higher than the 51Cr-EDTA clearance (110 versus 96 mL/min). In this first study, large dose 
of iohexol was injected to the patient (from 375 to 500 mg I/kg)(Olsson et al., 1983). 
Thereafter, the doses of iohexol used will be drastically reduced but it has been well 
described that the physiologic handling of iohexol was identical if different dosages are 
used (Back et al., 1988a). In table 5, we resumed the study results having compared the 
performance of iohexol to inulin in adult subjects. To the best of our knowledge, only two 
studies have compared urinary clearances of iohexol and inulin. The results seem excellent 
but Bland and Altman analysis have not been realized (Brown & O'Reilly, 1991;  Perrone et 
al., 1990). Contrary to other markers, iohexol plasmatic clearances have been the most 
studied.  The relatively worst results obtained by Erley are explained by the patients 
included (Erley et al., 2001). Actually, the patients hospitalized in intensive care are prone to 
develop edema and, in this situation, plasmatic clearances are not accurate, whatever the 
marker (Skluzacek et al., 2003). The study published by Gaspari demonstrated a good 
performance of iohexol plasma clearance compared to inulin but the number of samples was 
high and these samples were drawn lately (after 10h)(Gaspari et al., 1995). 
 
References Sample Population GFR range 
(mL/min/1.73 
m²) 
GFR methods Statistics Results 
(Lewis et al., 
1989) 
29 10 heart 
grafted 
11 renal grafted 
10 donors 
9.6 to 116.8 Inulin: urinary 
clearance and 
constant 
infused rate 
Iohexol (XRF) 
Plasma 
clearance: 
bolus and 
samples after 3 
and 4  
Correlation 
Regression 
Ratio 
0.86 
=0.85x+8.79 
1.09±0.06 
(Brown & 
O'Reilly, 
1991) 
30 NA ±10 to 125 Inulin: urinary 
clearance and 
constant 
infused rate 
Iohexol (XRF) 
urinary 
clearance and 
plasma 
clearance: 
samples at 3 
and 4 h +BM 
correction  
Correlation 
Regression 
Ratio 
Urinary 
0.986 
=0.998-2.309 
Plasma 
0.983 
=0.947+4.92 
=1.102±0.286 
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(Gaspari et 
al., 1995) 
41 CKD 6 to 160 Inulin: urinary 
clearance and 
constant 
infused rate 
Iohexol 
(HPLC) 
Plasma 
clearance, 
samples at 5, 
10, 20, 30, 45, 
60, 90, 120, 180, 
240, 300, 450, 
600 min 
Correlation 
Regression 
BA 
0.97 
=0.994x+2.339 
1.02±7 
 
(Erley et al., 
2001) 
31 intensive care ±10 to 130 Inulin: urinary 
clearance and 
constant 
infused rate 
Iohexol (XRF) 
Plasma 
clearance: 
samples at 150, 
195, 240 + 360 
min if 
estimated GFR 
under 30 
mL/min   
Correlation 
Regression 
BA 
=0.971x+7.65 
r²=0.96 
(Io-inulin) 
=8.67±7.21 
(Sterner et al., 
2008) 
20 healthy 106 to 129 Inulin: urinary 
clearance and 
constant 
infused rate 
Iohexol 
(HPLC) 
Urinary 
clearance and 
constant 
infused rate 
Wilcoxon Not different 
 
Table 5. Studies comparing iohexol with inulin. NA: not available, CKD: chronic kidney 
disease subjects, BA: Bland and Altman analysis, BAr: Bland and Altman analysis re-
calculated by us, BM: Brochner-Mortensen, HPLC: high pressure liquid chromatography, Io: 
iohexol, SC: subcutaneous, XRF: X ray fluorescence. 
8.3 Strengths and limitations 
Iohexol is probably the easiest way to measure GFR. It can be used in all patients (except in 
patient with true allergy to contrast product). Its measurement by HPLC is probably one of 
the most precise compared to other cold method (inulin and iothalamate). Iohexol is the less 
expensive marker and the cost of HPLC is also low. More important, it must be underlined 
that an external quality control does exist for iohexol measurement (Equalis, Sweden). From 
unpublished data, it can be concluded that the inter-laboratory CV for iohexol measurement 
is very low (less than 5%). Such results don’t exist for iothalamate and inulin, and, at least 
for inulin, we think that such good inter-laboratory results would not be reached (personal 
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data). The limitations of iohexol are the lack of strong physiological data (notably regarding 
the tubular handling of the marker) and the relatively few studies having compared iohexol 
with inulin. More studies have actually compared iohexol with other GFR markers.  
9. Studies comparing reference methods 
In Table 6, we resumed the results of studies comparing reference markers (other than 
inulin). We selected studies in adults. We focused on studies having used the best 
statistical methods to analyze the results, i.e. the Bland and Altman analysis. It is difficult 
to interpret results from studies having compared different markers but also different 
methods (for example, plasmatic clearance of iothalamate with urinary clearance of   51Cr-
EDTA) because it is impossible to affirm that potential differences are due to difference in 
markers or to difference in methods. Another limitation of several studies is the relatively 
small sample of subjects included. If we take into account these two limitations, we can 
stress on some interesting results showing good concordance (bias±SD) between plasma 
clearances of 51Cr-EDTA and 99Tc-DTPA (1.91±6.1 mL/min), and between plasma 
clearances of 51Cr-EDTA and  iohexol (-0.16±6.17 mL/min in (Brandstrom et al., 1998), 
4±7.9 mL/min in (Bird et al., 2009),  2±9.2 (Lundqvist et al., 1997), and -0.6±3.6 mL/min in 
(Pucci et al., 2001)). 
 
References Sample Population GFR range 
(mL/min/1.73 
m²) 
GFR 
methods 
Statistics Results 
(Odlind et al., 
1985) 
11 Nephrectomy 
and CKD 
37 to 137 Cp of Cr and 
125It: 
samples at 
180, 210 and 
240 min + BM 
correction  
Wilcoxon 
 
Ratio It/Cr 
BAr It-Cr 
It higher 
(p<0.001) 
1.13 
12±7.5 
(Lewis et al., 
1989) 
29 10 heart grafted 
11 renal grafted 
10 donors 
10 to 117 Cu of Dt and  
Io (XRF): 
samples at 3 
and 4 h after 
bolus 
Correlation 
Regression 
Ratio 
BAr Dt-Io 
0.89 
Io=0.89Dt+6.5 
1.08±0.06 
-0.7±14.8 
(Goates et al., 
1990) 
16 NA 21 to 156 Cu 125It: Cu 
after bolus IV 
and infusion 
Cp of Dt: 
samples at 60 
and 180 min+ 
BM correction 
Correlation 
BAr Io-Dt 
0.99 
3.2±6.1 
(Effersoe et 
al., 1990) 
15 urography 22 to 110 Cp of Io 
(XRF), Cr and 
Dt : samples 
at 0, 10, 20, 30, 
120, 180, 240 
and 300 min 
Regression 
Correlation 
 
 
BA : Cr-Io 
Dt-Io 
Cr-Dt 
Io=0.97Dt-11 
0.96 
Io=1.01Cr+8 
0.95 
-10.8±7.9 
-9.4±6.9 
-0.7±10.4 
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(Gaspari et 
al., 1992) 
19 CKD 7 to 148 Cp of Cr and 
It (HPLC): 
bolus IV and 
samples at 5, 
10, 20, 30, 40, 
50, 60, 90, 120, 
180, 240, 300, 
450 and 600 
min 
Correlation 
Regression 
BAr It-Cr 
0.995 
It=1.007Cr-0.303 
-0.1±4.7 
(Lundqvist et 
al., 1994) 
31 Para or 
tetraplegic 
±70 to 130 Cp of Cr and 
Io (XRF): 
samples à 180, 
210, 240 and 
270 minutes+ 
BM correction 
day 1 and 2 
BA Cr-Io Day 1 : +2.1±10.2 
Day 2 : +0.9±5.9 
(Galli et al., 
1994) 
50 NA ±15 to 160 Cp of Cr and 
Dt: samples at 
60 and 180 
min 
Regression 
BA Dt-Cr 
Dt=0.982Cr+3.2 
1.91±6.1 
 
(Sambataro 
et al., 1996)  
17 Diabetic 7 to 105  Cu of Cr and 
It (HPLC)  
Regression 
BAr It-Cr 
It=0.979Cr-3.04 
1.3±5 
(Lundqvist et 
al., 1997) 
77 Urography ±25 to 125  Cp of Cr and 
Io (XRF): 
samples at 
180, and 240 
or 270  
min+ BM 
correction  
Correlation 
Regression 
BA (Io-Cr) 
0.918 
Io=0.892Cr+6.28 
2±9.2 
(Brandstrom 
et al., 1998) 
49 GFR>40  ±40 to 125  Cp of Cr and 
Io (HPLC and 
XRF): samples 
at 150, 195 
and 240 min + 
BM correction 
 
Regression 
Correlation 
BA Cr-Io 
XRF 
Io=1.03Cr-1.79 
0.97 
0.58±4.95 
HPLC 
Io=1.05Cr-4.43 
0.96 
-0.16±6.17 
(Pucci et al., 
1998) 
32 Diabetic 13 to 151  Cp of Cr and 
Io (HPLC): 
samples at 5, 
10, 15, 30, 60, 
90, 120, 150, 
180, 210, 240, 
270, 300 + 360 
and 420 if 
creatinine>2
mg/dL + 
1440 min 
if>5mg/dL 
Regression 
Correlation 
BA Cr-Io 
0.995 
Io=0.978Cr+2.45 
-0.6±3.6 
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Houlihan 
(Houlihan et 
al., 1999) 
21 Diabetic 50 to 145  Cp of Dt and 
Io (XRF): 
samples at 
120, 165 and 
210 for Dt 
samples at 
120, 150, 180, 
210 and 240 
min for Io 
+ BM 
correction  
Regression 
Correlation 
BA Io-Dt 
Io=0.9938Dt+4.91
6 
0.97 
4.3±7.7 
(Pucci et al., 
2001) 
41 Diabetic 29 to 150  Cp of Cr and 
Io (HPLC): 
samples at 5, 
10, 15, 30, 60, 
90, 120, 150, 
180, 210, 240, 
270, 300 + 360 
and 420 if 
creatinine>2
mg/dL + 
1440 min 
if>5mg/dL  
 
Regression 
Correlation 
 
 
 
 
BA Cr-Io 
Type 1 
Io=0.978Cr+0.132 
0.999 
Type 2 
0.987 
Io=0.078Cr+2.352 
 
BA :-0.42±3.69 
Bird (Bird et 
al., 2009) 
56 
 
19 
CKD  
 
healthy 
±15 to 140  Cp of Cr and 
Io (XRF): 
samples at 20, 
40, 60, 120, 
180 and 240 
min 
BA Cr-Io 4±7.9 
Table 6. studies comparing different reference methods (other than inulin), NA = not 
available, BA: Bland and Altman, BAr: Bland and Altman recalculated by us, BM: Brochner 
Mortensen,Cr: 51Cr-EDTA, Dt: 99Tc-DTPA, Io: iohexol, It: iothalamate, Cp: plasma clearance, 
Cu: urinary clearance, IC: constant infusion rate, IB: bolus injection, IV: intravenous,  
SC: subcutaneous, AUC: area under the curve, NS: not significant, HPLC: high pressure 
liquid chromatography, XRF: X ray fluorescence. 
10. Conclusions and perspectives 
In this chapter, we reviewed all the reference methods available in 2011 to measure GFR. 
Among these methods, inulin clearance can certainly be considered as the gold-standard 
because it is historically the first method used and because this marker is certainly the best 
characterized from a physiological point of view. However, inulin is expensive and 
commercial sources are limited (Gaspari et al., 1997). Due to its high molecular weight, there 
are doubts to use inulin in simplified plasma clearance (urinary clearances with constant 
infusion rate remain necessary but are very cumbersome). Measurement of plasma inulin is 
neither easy nor standardized. For all these reasons, the use of inulin is and will always be 
relatively marginal. In 2011, it is maybe time to move from the perfect physiological marker 
(inulin) to markers, maybe less perfect in the renal physiologic handling, but less costly, 
easier to use everywhere in the world and with a standardized measurement. From our 
point of view, iohexol is probably the best marker with the best balance between 
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physiological characteristics and practical advantages. Additional studies comparing 
references markers seem necessary in 2011. It seems also important to underline that GFR 
measurement is also subject to its own imprecision and to biological variation (Kwong et al., 
2010). Therefore, it is illusionary to expect differences between different GFR methods of less 
than 10% (±2SD around the bias) and accuracy 10% over 85-90%. We must also keep these 
results in mind when we analyze the studies testing the performance of the creatinine-based 
equations (Kwong et al., 2010). 
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